Evidence map›Paper›PMID 41028355›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Coupling Recombinant PhyB to Cell Culture Plates and Beads.

Anna K Ehret, Lisa Entringer, Anne Smedegaard Frederiksen, Vincent Idstein, Sara Hartmann, Wolfgang W Schamel

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anna K EhretSignaling Research Centers BIOSS and CIBSS, Freiburg, Germany.
Lisa EntringerSignaling Research Centers BIOSS and CIBSS, Freiburg, Germany.
Anne Smedegaard FrederiksenSignaling Research Centers BIOSS and CIBSS, Freiburg, Germany.
Vincent IdsteinSignaling Research Centers BIOSS and CIBSS, Freiburg, Germany.
Sara HartmannSignaling Research Centers BIOSS and CIBSS, Freiburg, Germany.
Wolfgang W SchamelSignaling Research Centers BIOSS and CIBSS, Freiburg, Germany. wolfgang.schamel@biologie.uni-freiburg.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Optogenetics enables precise and reversible control of receptor activation using light-responsive proteins. In one approach, the first 651 amino acids of the photoreceptor phytochrome B (PhyB) of Arabidopsis thaliana are used as a light-responsive ligand for engineered receptors. These receptors are fused to the PhyB-interacting factor 6 (PIF) and bind to PhyB under red, but not under far-red light. The recombinant biotinylated PhyB ligand can be conjugated either to streptavidin-coated plates or to beads, enabling PIF-fused receptor activation with high valency. This method provides high spatiotemporal precision, offering potential for studying receptor signaling in two-dimensional cell-free interactions. Here, we provide protocols to couple recombinant PhyB to plastic plates or polystyrene beads and validate the coupling using light-dependent stimulation of green fluorescent protein (GFP)-PIF-fused T-cell receptors (TCRs) in primary human T cells.

Indexed as

Arabidopsis ProteinsCell Culture TechniquesOptogeneticsPhytochrome BArabidopsisGreen Fluorescent ProteinsHumansLightMicrospheresRecombinant Fusion ProteinsT-LymphocytesArabidopsis ProteinsGreen Fluorescent ProteinsPHYB protein, ArabidopsisPhytochrome BRecombinant Fusion ProteinsExtracellular optogeneticsPhytochrome BPrimary T cellsReceptor activation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.